Principal Investigator: Bruce L. Miller, M.D.
Medical Director: Bruce L. Miller, M.D.
The University of California, San Francisco (UCSF) Program for Alzheimer's
Disease Care and Education (PACE) was established in 1985 as one of six original
California Department of Health Services' Alzheimer's Disease Diagnostic
and Treatment Centers (ADDTCs). The Center was initially developed in the Department of
Psychiatry's Mental Health and Aging division at the Langley Porter Psychiatric
Institute (LPPI). The LPPI program has a long history of social science and
behavioral investigations that have led to improved understanding of caregiver
stress and patient care management across cultures.
In 1999, UCSF became an Alzheimer's Disease Research Center of California
(ARCC) with Dr. Bruce Miller as Principal Investigator and Medical Director. Dr.
Miller is a Professor of Neurology and Psychiatry at UCSF where he directs the
aging and dementia program. Dr. Miller was recruited to UCSF in the fall of 1998
in order to establish a clinical dementia program, and holds the A.W. and Mary
Margaret Clausen Distinguished Chair. Since his arrival, Dr. Miller has
established strong linkages between existing clinical, research, and basic
science programs and community agencies. The UCSF ARCC has been organized to
provide outstanding diagnostic and treatment services to individuals with
dementia and to their families.
One of the primary focuses of research at UCSF is to learn more about the
clinical, genetic, imaging, emotional and diagnostic features of frontotemporal
lobar degeneration (FTLD), also referred to as frontotemporal dementia or Pick's
disease. The purpose of these studies is to collect longitudinal clinical,
imaging, behavioral, and autopsy data to be analyzed with the goal of improving
clinical care for patients with FTLD.
In 2003, UCSF was designated as a national Alzheimer's Disease Research
Center (ADRC). Funded by the National Institutes of Health, this large
collaborative project is composed of multiple institutions and locations. It is
designed to integrate basic science and clinical resources in order to
investigate the clinical, molecular, neuropathological and neuroimaging features
of Alzheimer's disease (AD), non-AD dementias, and mild cognitive impairment
(MCI).
Alzheimer's Disease
Program
Mail Station 7210
Post Office Box 997413
Sacramento, CA 95899-7413
Phone (916) 552-8995
Fax (916) 552-9910
Internet: www.dhs.ca.gov/Alzheimers/
